acyclovir
- Product NDC
- 63187-366
- 11-digit product format
- 631870366
- Labeler code
- 63187
- Product ID
- 63187-366_0f60482e-7e09-458c-9854-ea4578a08c4a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA204314
- Marketing category
- ANDA
- Marketing start
- 2014-09-10
- Substance
- ACYCLOVIR
- Active strength
- 800 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204314-001 | ACYCLOVIR | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | |
| A204314-002 | ACYCLOVIR | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A204314-001 | AB |
| A204314-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A204314-001 | ACYCLOVIR | 400MG | TABLET / ORAL | AB | 2014-08-19 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | A204314-002 | ACYCLOVIR | 800MG | TABLET / ORAL | AB | 2014-08-19 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A204314-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A204314-002 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204314-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204314-002 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A204314-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A204314-002 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204314-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204314-002 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204314-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204314-002 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204314-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204314-002 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204314-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204314-002 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204314-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204314-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204314-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204314-002 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A204314-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A204314-002 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204314-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204314-002 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204314-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204314-002 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204314-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204314-002 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A204314-001 | AB | 1 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | A204314-002 | AB | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204314-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204314-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A204314-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A204314-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A204314-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A204314-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A204314-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A204314-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A204314-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A204314-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A204314-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A204314-002 | AB | 1 | 782e0a99824c… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- acyclovir
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACYCLOVIR | 800 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| X4HES1O11F | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 197313 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3da54b2d-a206-4ff5-8cc2-90762c4fd70d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 33190c02-82e1-0a4d-d716-9ccd23588463 | Product name | 5 | 20250225 |
| c367d1da-5a72-8966-6d11-1eb9a73ae758 | Product name | 3 | 20231115 |
| 5518bf13-db2f-2e9c-3679-e70ecf03752c | Product name | 9 | 20210614 |
| 27897900-0e40-497b-97e1-88057e68fe6c | Product name | 4 | 20200710 |
| ca834e59-e669-229c-9288-0ccb76dc373e | Product name | 9 | 20200220 |
| d7f95c49-d3e1-4bbc-a389-e9cd73f59a28 | Product name | 1 | 20190702 |
| fb15b394-3715-4c87-a447-421489aa8739 | Product name | 3 | 20170727 |
| 7bdc4804-3832-c0df-e519-72b6d47c9792 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63187-366-30 | acyclovir | 30 in 1 BOTTLE | TABLET | 30 | 3 | |
| 63187-366-35 | acyclovir | 35 in 1 BOTTLE | TABLET | 35 | 3 | |
| 63187-366-60 | acyclovir | 60 in 1 BOTTLE | TABLET | 60 | 3 | |
| 63187-366-90 | acyclovir | 90 in 1 BOTTLE | TABLET | 90 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| acyclovir | ACYCLOVIR | Northwind Health Company, LLC | 50c58161-3944-7367-e063-6394a90a6286 | 2026-04-29 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 960e4ede-692e-4db2-a96e-dc6f4a6190ee | 2026-04-03 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | REMEDYREPACK INC. | 8fdabab2-bc93-48ab-9c13-d22ec90fdcfc | 2026-02-27 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | Zydus Lifesciences Limited | 8d9fea43-6c04-40d7-8aac-398c2de2a558 | 2025-11-27 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | Zydus Pharmaceuticals (USA) Inc. | edb0cd28-ee57-4b60-be94-62c797fbf5e6 | 2025-11-27 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | Coupler LLC | 2cdbea8d-29df-0045-e063-6294a90a9506 | 2025-01-29 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | NuCare Pharmaceuticals, Inc. | 40e5cc54-ed74-3369-e054-00144ff88e88 | 2024-08-14 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | f3e6b1ad-810b-4f53-b92a-b28fc2111f3f | 2024-01-25 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | A-S Medication Solutions | c40a57b9-4cf1-4a69-abf3-eb99a7fcda00 | 2023-04-16 | Warnings, Adverse reactions | 204314 ANDA204314 |
| acyclovir | ACYCLOVIR | Proficient Rx LP | 3da54b2d-a206-4ff5-8cc2-90762c4fd70d | 2021-01-01 | Warnings, Adverse reactions | 204314 ANDA204314 63187-366 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 197313 | acyclovir 800 MG Oral Tablet | PSN | 3da54b2d-a206-4ff5-8cc2-90762c4fd70d | 3 |
| 197313 | acyclovir 800 MG Oral Tablet | SCD | 3da54b2d-a206-4ff5-8cc2-90762c4fd70d | 3 |
| 197313 | acycycloguanosine 800 MG Oral Tablet | SY | 3da54b2d-a206-4ff5-8cc2-90762c4fd70d | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63187-366-30 | 63187036630 | 30 TABLET in 1 BOTTLE (63187-366-30) | 30 tablet | 2016-08-18 | 0000-00-00 | No | No | Current |
| 63187-366-35 | 63187036635 | 35 TABLET in 1 BOTTLE (63187-366-35) | 35 tablet | 2016-08-18 | 0000-00-00 | No | No | Current |
| 63187-366-60 | 63187036660 | 60 TABLET in 1 BOTTLE (63187-366-60) | 60 tablet | 2016-08-18 | 0000-00-00 | No | No | Current |
| 63187-366-90 | 63187036690 | 90 TABLET in 1 BOTTLE (63187-366-90) | 90 tablet | 2016-08-18 | 0000-00-00 | No | No | Current |